| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 359466 | Null | 0.0138010872611484 | 0.12849666 |
| NSC 367480 | Null | 0.0138010872611484 | 0.48245866 |
| NSC 657174 | Null | 0.0138010872611484 | 0.058062944 |
| NSC 671883 | Null | 0.0138010872611484 | 0.53209357 |
| NSC 6926 | Null | 0.0138010872611484 | 0.35138375 |
| NSC 693248 | Null | 0.0138010872611484 | 0.1695716 |
| NSC 709358 | 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol | 0.0138010872611484 | 0.14622675 |
| NSC 727620 | 6-[3-(2-Aminoethylamino)]-bis{1-propyl)-5,6-dihydro-2,3-dime thoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquin oline} dihydrochloride | 0.0138010872611486 | 0.14784886 |
| NSC 732936 | 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline | 0.0138010872611486 | 0.13968988 |
| NSC 743694 | Null | 0.0138010872611486 | 0.36257706 |